B C John Cho Selected Research

Mesothelioma

1/2021	Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.
1/2021	Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma.
11/2020	Foxp3+ Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma.
1/2020	Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma.
1/2019	The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
3/2014	A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B C John Cho Research Topics

Disease

10	Neoplasms (Cancer) 02/2024 - 12/2011
10	Malignant Mesothelioma 01/2021 - 03/2009
6	Mesothelioma 01/2021 - 03/2014
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2013
4	Breast Neoplasms (Breast Cancer) 04/2012 - 01/2004
3	Squamous Cell Carcinoma of Head and Neck 02/2024 - 03/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014 - 12/2013
2	Lung Neoplasms (Lung Cancer) 01/2019 - 07/2014
2	Oropharyngeal Neoplasms 01/2013 - 04/2012
1	Radiation Pneumonitis 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Hypopharyngeal Neoplasms 05/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2013
1	Carcinoma (Carcinomatosis) 01/2013
1	Sarcoma (Soft Tissue Sarcoma) 10/2012
1	Laryngeal Neoplasms (Laryngeal Cancer) 10/2012
1	Seroma 04/2012
1	AIDS-Related Complex (ARC) 12/2011
1	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2011
1	Pleural Diseases 07/2010
1	Unilateral Breast Neoplasms 03/2004

Drug/Important Bio-Agent (IBA)

1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	Circulating Tumor DNAIBA 02/2024
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	GlucocorticoidsIBA 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 11/2020
1	Granzymes (Granzyme)IBA 11/2020
1	Peptides (Polypeptides)IBA 07/2010
1	MesothelinIBA 07/2010
1	OsteopontinIBA 07/2010

Therapy/Procedure

22	Radiotherapy 01/2021 - 01/2004
7	Therapeutics 02/2024 - 03/2009
7	Pneumonectomy (Lung Volume Reduction) 01/2021 - 03/2009
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 03/2004
2	Segmental Mastectomy (Lumpectomy) 04/2012 - 12/2011
1	Combined Modality Therapy 01/2021
1	Re-Irradiation 01/2019
1	Neoadjuvant Therapy 06/2017
1	Salvage Therapy 10/2015
1	Chemoradiotherapy 01/2013
1	Drug Therapy (Chemotherapy) 01/2013
1	Induction Chemotherapy 03/2009